2 Dec 2020 09:00
02 December 2020
OMEGA DIAGNOSTICS GROUP PLC
("Omega" or the "Company" or the "Group")
Director / PDMR Dealings
Omega Diagnostics (AIM: ODX), the medical diagnostics company focused on CD4, infectious diseases and food intolerance testing, announces that on 1 December 2020 Colin King, Chief Executive Officer, bought 35,721 Ordinary Shares of 4 pence each in the Company, at a price of 53.19 pence per share.
Following completion, Mr King is interested in 853,973 Ordinary Shares, representing 0.47 per cent. of the issued share capital of the Company.
The FCA notification, made in accordance with the requirements of the EU Market Abuse Regulation is appended below.
The information communicated in this announcement is inside information for the purposes of Article 7 of EU Regulation 596/2014.
Contacts:
Omega Diagnostics Group PLC | Tel: 01259 763 030 |
Colin King, Chief Executive | www.omegadiagnostics.com |
Kieron Harbinson, Group Finance Director | |
finnCap Ltd | Tel: 020 7220 0500 |
Geoff Nash/Teddy Whiley (Corporate Finance) | |
Alice Lane (ECM) | |
Walbrook PR Limited | Tel: 020 7933 8780 or omega@walbrookpr.com |
Paul McManus | Mob: 07980 541 893 |
Lianne Cawthorne | Mob: 07584 391 303 |
| Details of the person discharging managerial responsibilities/person closely associated | |||||
a) | Name: | Colin King | ||||
| Reason for the notification | |||||
a) | Position/status: | Chief Executive Officer | ||||
b) | Initial notification/Amendment: | Initial Notification | ||||
| Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | |||||
a) | Name: | Omega Diagnostics Group Plc | ||||
b) | LEI: | 2138007U9P4BTZTYIR92 | ||||
| Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |||||
a) | Description of the financial instrument, type of instrument: Identification code: | Ordinary Shares of 4 pence each GB00B1VCP282
| ||||
b) | Nature of the transaction: | Purchase of Ordinary Shares | ||||
c) | Price(s) and volume(s): |
| ||||
d) | Aggregated information: · Aggregated volume: · Price: | Single transaction as in 4 c) above
| ||||
e) | Date of the transaction: | 1 December 2020 | ||||
f) | Place of the transaction: | LSE | ||||
ODX.L (ODX)